[go: up one dir, main page]

MX9708877A - P62, sus variantes, las secuencias de acidos nucleicos que los codifican, y su utilizacion en terapia genica anti-cancerosa. - Google Patents

P62, sus variantes, las secuencias de acidos nucleicos que los codifican, y su utilizacion en terapia genica anti-cancerosa.

Info

Publication number
MX9708877A
MX9708877A MX9708877A MX9708877A MX9708877A MX 9708877 A MX9708877 A MX 9708877A MX 9708877 A MX9708877 A MX 9708877A MX 9708877 A MX9708877 A MX 9708877A MX 9708877 A MX9708877 A MX 9708877A
Authority
MX
Mexico
Prior art keywords
delta
variants
nucleic acid
acid sequences
sam68
Prior art date
Application number
MX9708877A
Other languages
English (en)
Other versions
MXPA97008877A (es
Inventor
Fabien Schweighoffer
Bruno Tocoue
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of MX9708877A publication Critical patent/MX9708877A/es
Publication of MXPA97008877A publication Critical patent/MXPA97008877A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion describe un péptido novedoso designado como ??P62 o??Sam68, las variantes del mismo, las secuencias de ácidos nucleicos correspondientes, y los usos de los mismos, particularmente en terapia génica anticancerosa.
MXPA/A/1997/008877A 1995-06-01 1997-11-18 P62, sus variantes, las secuencias de acidos nucleicos que los codifican, y su utilizacion en terapia genica anti-cancerosa MXPA97008877A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR95/06533 1995-06-01
FR9506533 1995-06-01
FR9506533A FR2734826B1 (fr) 1995-06-01 1995-06-01 Deltap62, ses variants, sequences nucleiques et leurs utilisations
PCT/FR1996/000802 WO1996038556A2 (fr) 1995-06-01 1996-05-29 Deltap62, ses variants, sequences d'acides nucleiques les codant, et leurs utilisations en therapie genique anti-cancereuse

Publications (2)

Publication Number Publication Date
MX9708877A true MX9708877A (es) 1998-03-31
MXPA97008877A MXPA97008877A (es) 1998-10-15

Family

ID=

Also Published As

Publication number Publication date
CZ375997A3 (cs) 1998-02-18
FR2734826A1 (fr) 1996-12-06
SK283071B6 (sk) 2003-02-04
EP0828832A2 (fr) 1998-03-18
WO1996038556A3 (fr) 1997-01-09
AU6129196A (en) 1996-12-18
SK161397A3 (en) 1998-07-08
KR19990022193A (ko) 1999-03-25
HUP9901346A2 (hu) 1999-08-30
AU718889B2 (en) 2000-04-20
WO1996038556A2 (fr) 1996-12-05
IL118493A0 (en) 1996-09-12
JPH11506325A (ja) 1999-06-08
US6544948B1 (en) 2003-04-08
NO975409D0 (no) 1997-11-25
NO975409L (no) 1997-11-25
ZA964392B (en) 1996-12-09
HUP9901346A3 (en) 2000-10-30
CA2219861A1 (fr) 1996-12-05
CZ291533B6 (cs) 2003-03-12
FR2734826B1 (fr) 1997-07-04
BR9608632A (pt) 1999-05-04

Similar Documents

Publication Publication Date Title
IL110284A0 (en) Viral vectors and their use in gene therapy
EP0679716A4 (en) GENE SIGNATURE.
AU1235392A (en) Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof
EP0623171A4 (en) ENZYMATIC RNA MOLECULES.
AU699706C (en) Improved vectors for gene therapy
AU8547691A (en) Protein sequence-specific oligonucleotide sequences
HUP9801639A3 (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor
AU6212094A (en) Anti-stall tip treatment means
AU7019494A (en) Genetic therapy for cardiovascular disease
IL96907A0 (en) Proteins produced by human lymphocytes,a dna sequence coding for said proteins and their pharmaceutical and biological application
AU6713894A (en) Natural or recombinant dna binding proteins as carriers for gene transfer or gene therapy
AU2682495A (en) Novel transferase and amylase, process for producing the enzymes,use thereof, and gene coding for the same
SI0727489T1 (sl) DNA sekvenca ki kodira protein A thaliane z aktivnostjo delta sterol delta reduktaze protein delta Red postopek za pripravo transformirani sevi kvasovk in uporabe
WO1995030001A3 (en) Novel p-selectin ligand protein
WO1997012963A3 (en) A paf-acetylhydrolase and use in therapy
AU3698297A (en) Compositions containing at least one nucleic acid and their applications in the biomedical field, particularly in gene therapy
AU1720397A (en) Recombinant expression of s-layer proteins
AU3670395A (en) Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
AU6483896A (en) Nucleotide and amino acid sequence and uses thereof
AU2053999A (en) Regulatory sequences involved in pancreas-specific gene expression
AU2043597A (en) Human taki dna encoding the same
WO1996038556A3 (fr) Deltap62, ses variants, sequences d'acides nucleiques les codant, et leurs utilisations en therapie genique anti-cancereuse
AU6260796A (en) Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof
EP0658196A4 (en) GENE INSERTION BY DIRECT -i (IN VITRO) LINK.
TW342413B (en) Novel toxins isolated from Bracon Hebetor